As we have shown that human PRMT1 serves as a negative regulator of necroptosis in human colon cancer by methylating RIP3, we are interested in knowing whether murine PRMT1 (mPRMT1) is consistently involved in RIP3 methylation and necroptosis inhibition. Here, PRMT1 is linked to colonic neoplasm.